PTC Therapeutics (NASDAQ:PTCT) Shares Up 6.1% Following Analyst Upgrade
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) shot up 6.1% during trading on Monday after Cantor Fitzgerald raised their price target on the stock from $76.00 to $113.00. Cantor Fitzgerald currently has an overweight rating on the stock.
StockStory.org on MSN21h
PTC Earnings: What To Look For From PTCEngineering and design software provider PTC (NASDAQ:PTC) will be reporting earnings tomorrow afternoon. Here’s what to ...
Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating ...
Zacks.com on MSN1d
PTC to Report Q1 Earnings: Here's What Investors Should KnowPTC Inc PTC is scheduled to report first-quarter fiscal 2025 results on Feb. 5. Stay up-to-date with all quarterly releases: ...
Poonam Gupta will tie the knot on February 12 with assistant commandant, Avneesh Kumar currently posted in Jammu and Kashmir.
Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...
The stock's fall snapped a two-day winning streak.
Check the time stamp on this data. Updated AI-Generated Signals for Ptc Inc. (PTC) available here: PTC. Type a few symbols ...
Loop Capital Markets analyst Yun Kim maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $240.00. The ...
Shares of PTC Inc. PTC advanced 1.30% to $190.93 Tuesday, on what proved to be an all-around great trading session for the ...
The U.S. Department of the Treasury and IRS on Jan. 10, 2025, released initial guidance regarding the production tax credit (PTC) for clean ...
Over the past month, PTC Inc. PTC stock increased by 5.53%, and in the past year, by 8.06%. With performance like this, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback